← KEWAUNEE SCIENTIFIC CORP /DE/ KEQU
Market Price
$35.90
Market Cap
$102.89M
P/E Ratio
9.37
Revenue (FY 2026)
$240.47M
Full year reported
Net Income
$11.40M
Net Margin: N/A
Free Cash Flow
↑16.5% YoY
$14.70M
FCF Yield: 14.28%
EPS (Diluted)
$3.83
Basic: $3.98
Return on Equity
Efficiency
17.7%
ROA: 191.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (KEQU)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $128.6M | — | $23.7M | $3.8M | — | $1.42 | — | — | — | — |
| FY 2017 | $138.6M | +7.7% | $26.6M | $4.5M | +18.8% | $1.66 | +16.9% | $11.7M | $9.1M | — |
| FY 2018 | $158.1M | +14.1% | $32.0M | $5.2M | +14.9% | $1.87 | +12.7% | $3.2M | $-0.2M | -102.3% |
| FY 2019 | $146.6M | -7.3% | $25.3M | $1.5M | -70.5% | $0.55 | -70.6% | $2.5M | $-1.7M | -712.7% |
| FY 2020 | $147.5M | +0.7% | $23.4M | $-4.7M | -406.5% | $-1.70 | -409.1% | $4.2M | $1.7M | +198.4% |
| FY 2021 | $147.5M | -0.0% | $24.0M | $-3.7M | +21.7% | $-1.33 | +21.8% | $0.9M | $-1.5M | -187.6% |
| FY 2022 | $168.9M | +14.5% | $24.2M | $-6.1M | -66.8% | $-2.20 | -65.4% | $-7.9M | $-9.8M | -559.5% |
| FY 2023 | $219.5M | +30.0% | $35.6M | $0.7M | +112.0% | $0.25 | +111.4% | $-3.8M | $-7.9M | +18.9% |
| FY 2024 | $203.8M | -7.2% | $52.1M | $18.8M | +2,441.1% | $6.38 | +2,452.0% | $19.6M | $15.2M | +291.4% |
| FY 2025 | $240.5M | +18.0% | $68.9M | $11.4M | -39.2% | $3.83 | -40.0% | $14.8M | $12.6M | -16.9% |
| FY 2026 | — | — | — | — | — | — | — | $18.6M | $14.7M | +16.5% |
Valuation
Market Price
$35.90
Market Cap
$102.89M
Enterprise Value
N/A
P/E Ratio
9.37
P/B Ratio
1.60
FCF Yield
14.28%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
17.69%
Return on Assets (ROA)
191.17%
Asset Turnover
40.31x
Revenue 3-Yr CAGR
N/A
Financial Health & Liquidity
Current Ratio
3.95
Cash Ratio
9.90
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$14.94M
Total Debt
N/A
Book Value / Share
$22.49
Cash Flow Efficiency
Operating Cash Flow
$18.63M
Capital Expenditures (CapEx)
$3.94M
Free Cash Flow
$14.70M
OCF / Revenue
7.75%
FCF / Revenue
6.11%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$3.83
EPS (Basic)
$3.98
Dividends / Share
N/A
Book Value / Share
$22.49
EPS YoY Growth
N/A
Balance Sheet (FY 2026)
Total Assets
$5.97M
Total Liabilities
$1.51M
Stockholders' Equity
$64.46M
Current Assets
$5.97M
Current Liabilities
$1.51M